According to the latest market research study by Technavio, the global MRSA testing market is expected to grow at a CAGR of close to 11% during the forecast period of 2017 to 2021.
This report by Technavio provides an in-depth analysis of the global MRSA testing market in terms of revenue and emerging market trends. The report also includes a competitive vendor analysis and forecasts for various market segments and all geographical regions.
Technavio research analysts categorize the market based on the product
Click here to request a free sample of this report
POC: Point-of-care (POC) is one of the leading contributor segment in the global MRSA testing market. It has the largest market share and growth rate due to the high number of RIDT procedures performed for MRSA treatment. Several manufacturers in the market are focusing on product expansion in POC segment. For instance, GeneXpert Omni from Cepheid (Danaher), is a point of care testing devices that gives results within 3-5 hours.
“POC proved to be advantageous when MRSA PCR assay Xpert MRSA from Cepheid was used for POC of MRSA nasal swab samples; the results were compared with the culture test of nasal swab sample. It was found that POC was easier to use, the turnaround time was reduced, and the sensitivity of the test also increased,” says Sapna Jha, a lead analyst at Technavio for research on in-vitro diagnostics.
Immunodiagnostics: The global MRSA immunodiagnostics market is anticipated to grow rapidly during the forecast period.The high demand for high throughput screening with the help of immunoassays has led to the production of new substances. The application of fluorescence and chemiluminescence immunoassay technologies with new reagents has also increased. The growing number of immunodiagnostics available in the market requires companies to improve their product portfolios for test reagents.
Molecular diagnostics: Molecular diagnostic tests detect an individual or infecting pathogen’s deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). It employs technologies such as polymerase chain reaction (PCR), sequencing, microarray, and next-generation sequencing (NGS). The revenues from molecular testing segment include product sales of analytical/pre-analytical platforms and kits used for detecting MRSA infections.
Ask an analyst to know more about this report
The top vendors operating in the global MRSA testing market are:
- Becton Dickinson
- Biomérieux
- Roche Diagnostics
The other prominent vendors in the market include 3M, Abacus Diagnostica, AdvanDX, Alere, Arlington Scientific, Atlas Genetics, Bio-Rad Laboratories, Cepheid, Diatherix Laboratories, DxNA, Hain Lifescience, Luminex, Puritan Medical, and R-Biopharm.
A more detailed analysis is available in the Technavio market research report titled, ‘Global MRSA Testing Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports
- Global Cervical Cancer Diagnostic Testing Market 2016-2020
- Global Non-Invasive Prenatal Testing Market 2016-2020
- Global Enteric Disease Testing Market 2016-2020
To read more press releases – click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
